About: OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.16 (+0.87%)
OSTX NYSE OS Therapies Incorporated
OS Therapies Incorporated share price
OSTX price activity
Last Price
$1.160
Change (24hr)
0.01 USD (0.87%)
Volume
439.30K
Volume (4w avg)
-
Open
$1.16
Day Range
$1.15 - $1.22
Previous Close
$1.15
Last Trade
03 Nov, 9:25 pm GMT+0
Delayed
03 Nov, 9:25 pm GMT+0
OSTX price performance
Delayed
03 Nov, 9:25 pm GMT+0
OSTX details
OSTX Market Signals